nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Rosuvastatin—atherosclerosis	0.113	0.149	CbGbCtD
Mifepristone—CYP3A7—Simvastatin—atherosclerosis	0.0521	0.0687	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0521	0.0687	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.051	0.0672	CbGbCtD
Mifepristone—CYP3A7—Lovastatin—atherosclerosis	0.051	0.0672	CbGbCtD
Mifepristone—CYP3A5—Rosuvastatin—atherosclerosis	0.042	0.0554	CbGbCtD
Mifepristone—CYP3A5—Simvastatin—atherosclerosis	0.0391	0.0515	CbGbCtD
Mifepristone—CYP3A5—Lovastatin—atherosclerosis	0.0382	0.0504	CbGbCtD
Mifepristone—CYP3A5—Pravastatin—atherosclerosis	0.0382	0.0504	CbGbCtD
Mifepristone—CYP2D6—Niacin—atherosclerosis	0.0303	0.04	CbGbCtD
Mifepristone—ABCB1—Ezetimibe—atherosclerosis	0.0274	0.0361	CbGbCtD
Mifepristone—ABCB1—Simvastatin—atherosclerosis	0.0254	0.0335	CbGbCtD
Mifepristone—ABCB1—Pravastatin—atherosclerosis	0.0249	0.0328	CbGbCtD
Mifepristone—ABCB1—Lovastatin—atherosclerosis	0.0249	0.0328	CbGbCtD
Mifepristone—CYP2D6—Simvastatin—atherosclerosis	0.024	0.0316	CbGbCtD
Mifepristone—CYP2D6—Lovastatin—atherosclerosis	0.0235	0.0309	CbGbCtD
Mifepristone—CYP2D6—Pravastatin—atherosclerosis	0.0235	0.0309	CbGbCtD
Mifepristone—CYP3A4—Ezetimibe—atherosclerosis	0.0164	0.0216	CbGbCtD
Mifepristone—CYP3A4—Rosuvastatin—atherosclerosis	0.0164	0.0216	CbGbCtD
Mifepristone—CYP3A4—Simvastatin—atherosclerosis	0.0152	0.0201	CbGbCtD
Mifepristone—CYP3A4—Pravastatin—atherosclerosis	0.0149	0.0197	CbGbCtD
Mifepristone—CYP3A4—Lovastatin—atherosclerosis	0.0149	0.0197	CbGbCtD
Mifepristone—AR—penis—atherosclerosis	0.00195	0.206	CbGeAlD
Mifepristone—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00187	0.013	CcSEcCtD
Mifepristone—Rash maculo-papular—Niacin—atherosclerosis	0.00134	0.00936	CcSEcCtD
Mifepristone—Breast disorder—Rosuvastatin—atherosclerosis	0.00133	0.00928	CcSEcCtD
Mifepristone—Hot flush—Ezetimibe—atherosclerosis	0.00131	0.00913	CcSEcCtD
Mifepristone—Muscular weakness—Rosuvastatin—atherosclerosis	0.0013	0.00906	CcSEcCtD
Mifepristone—Menopausal symptoms—Ezetimibe—atherosclerosis	0.0013	0.00905	CcSEcCtD
Mifepristone—Pain in extremity—Lovastatin—atherosclerosis	0.00125	0.00871	CcSEcCtD
Mifepristone—Pain in extremity—Ezetimibe—atherosclerosis	0.00122	0.00854	CcSEcCtD
Mifepristone—PGR—artery—atherosclerosis	0.00113	0.12	CbGeAlD
Mifepristone—Hot flush—Pravastatin—atherosclerosis	0.00113	0.00787	CcSEcCtD
Mifepristone—Cramp muscle—Lovastatin—atherosclerosis	0.00112	0.00784	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00112	0.00784	CcSEcCtD
Mifepristone—Menopausal symptoms—Pravastatin—atherosclerosis	0.00112	0.0078	CcSEcCtD
Mifepristone—Breast disorder—Ezetimibe—atherosclerosis	0.00111	0.00772	CcSEcCtD
Mifepristone—Cramp muscle—Ezetimibe—atherosclerosis	0.0011	0.00769	CcSEcCtD
Mifepristone—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00109	0.00764	CcSEcCtD
Mifepristone—Muscular weakness—Ezetimibe—atherosclerosis	0.00108	0.00753	CcSEcCtD
Mifepristone—Sinusitis—Rosuvastatin—atherosclerosis	0.00107	0.00743	CcSEcCtD
Mifepristone—Cramp muscle—Simvastatin—atherosclerosis	0.00105	0.00733	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00105	0.00733	CcSEcCtD
Mifepristone—Muscular weakness—Simvastatin—atherosclerosis	0.00103	0.00718	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000951	0.00663	CcSEcCtD
Mifepristone—Cramp muscle—Pravastatin—atherosclerosis	0.000951	0.00663	CcSEcCtD
Mifepristone—Muscular weakness—Niacin—atherosclerosis	0.000946	0.00659	CcSEcCtD
Mifepristone—Nasopharyngitis—Pravastatin—atherosclerosis	0.000944	0.00658	CcSEcCtD
Mifepristone—Infestation NOS—Ezetimibe—atherosclerosis	0.000944	0.00658	CcSEcCtD
Mifepristone—Infestation—Ezetimibe—atherosclerosis	0.000944	0.00658	CcSEcCtD
Mifepristone—Muscular weakness—Pravastatin—atherosclerosis	0.000931	0.00649	CcSEcCtD
Mifepristone—Sinusitis—Lovastatin—atherosclerosis	0.000903	0.00629	CcSEcCtD
Mifepristone—Mental disorder—Rosuvastatin—atherosclerosis	0.000893	0.00623	CcSEcCtD
Mifepristone—Sinusitis—Ezetimibe—atherosclerosis	0.000885	0.00617	CcSEcCtD
Mifepristone—PGR—blood vessel—atherosclerosis	0.000882	0.0933	CbGeAlD
Mifepristone—Sinusitis—Simvastatin—atherosclerosis	0.000844	0.00589	CcSEcCtD
Mifepristone—Oedema peripheral—Ezetimibe—atherosclerosis	0.000834	0.00582	CcSEcCtD
Mifepristone—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000832	0.0058	CcSEcCtD
Mifepristone—Angioedema—Rosuvastatin—atherosclerosis	0.000811	0.00565	CcSEcCtD
Mifepristone—Chills—Lovastatin—atherosclerosis	0.000775	0.0054	CcSEcCtD
Mifepristone—Angiopathy—Ezetimibe—atherosclerosis	0.000769	0.00536	CcSEcCtD
Mifepristone—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000763	0.00532	CcSEcCtD
Mifepristone—Sinusitis—Pravastatin—atherosclerosis	0.000763	0.00532	CcSEcCtD
Mifepristone—Arthralgia—Rosuvastatin—atherosclerosis	0.000755	0.00527	CcSEcCtD
Mifepristone—Myalgia—Rosuvastatin—atherosclerosis	0.000755	0.00527	CcSEcCtD
Mifepristone—Haemoglobin—Niacin—atherosclerosis	0.000746	0.0052	CcSEcCtD
Mifepristone—Mental disorder—Ezetimibe—atherosclerosis	0.000742	0.00517	CcSEcCtD
Mifepristone—Haemorrhage—Niacin—atherosclerosis	0.000742	0.00517	CcSEcCtD
Mifepristone—Malnutrition—Ezetimibe—atherosclerosis	0.000737	0.00514	CcSEcCtD
Mifepristone—Oedema peripheral—Niacin—atherosclerosis	0.000731	0.0051	CcSEcCtD
Mifepristone—Back pain—Lovastatin—atherosclerosis	0.000727	0.00507	CcSEcCtD
Mifepristone—Chills—Simvastatin—atherosclerosis	0.000725	0.00505	CcSEcCtD
Mifepristone—Muscle spasms—Lovastatin—atherosclerosis	0.000723	0.00504	CcSEcCtD
Mifepristone—Infection—Rosuvastatin—atherosclerosis	0.000719	0.00502	CcSEcCtD
Mifepristone—Back pain—Ezetimibe—atherosclerosis	0.000713	0.00497	CcSEcCtD
Mifepristone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00071	0.00495	CcSEcCtD
Mifepristone—Muscle spasms—Ezetimibe—atherosclerosis	0.000709	0.00494	CcSEcCtD
Mifepristone—Mental disorder—Simvastatin—atherosclerosis	0.000708	0.00494	CcSEcCtD
Mifepristone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000698	0.00486	CcSEcCtD
Mifepristone—Angioedema—Lovastatin—atherosclerosis	0.000687	0.00479	CcSEcCtD
Mifepristone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000684	0.00477	CcSEcCtD
Mifepristone—Malaise—Lovastatin—atherosclerosis	0.000678	0.00473	CcSEcCtD
Mifepristone—Muscle spasms—Simvastatin—atherosclerosis	0.000676	0.00471	CcSEcCtD
Mifepristone—Angioedema—Ezetimibe—atherosclerosis	0.000674	0.0047	CcSEcCtD
Mifepristone—Angiopathy—Niacin—atherosclerosis	0.000673	0.00469	CcSEcCtD
Mifepristone—Chills—Niacin—atherosclerosis	0.000666	0.00464	CcSEcCtD
Mifepristone—Malaise—Ezetimibe—atherosclerosis	0.000665	0.00464	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00066	0.0046	CcSEcCtD
Mifepristone—Chills—Pravastatin—atherosclerosis	0.000655	0.00457	CcSEcCtD
Mifepristone—Insomnia—Rosuvastatin—atherosclerosis	0.000655	0.00457	CcSEcCtD
Mifepristone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000652	0.00455	CcSEcCtD
Mifepristone—Malnutrition—Niacin—atherosclerosis	0.000646	0.0045	CcSEcCtD
Mifepristone—Angioedema—Simvastatin—atherosclerosis	0.000643	0.00448	CcSEcCtD
Mifepristone—Arthralgia—Lovastatin—atherosclerosis	0.00064	0.00446	CcSEcCtD
Mifepristone—Myalgia—Lovastatin—atherosclerosis	0.00064	0.00446	CcSEcCtD
Mifepristone—Anxiety—Lovastatin—atherosclerosis	0.000638	0.00445	CcSEcCtD
Mifepristone—Hypertension—Ezetimibe—atherosclerosis	0.000637	0.00444	CcSEcCtD
Mifepristone—Malaise—Simvastatin—atherosclerosis	0.000634	0.00442	CcSEcCtD
Mifepristone—Discomfort—Lovastatin—atherosclerosis	0.000632	0.00441	CcSEcCtD
Mifepristone—Myalgia—Ezetimibe—atherosclerosis	0.000628	0.00438	CcSEcCtD
Mifepristone—Arthralgia—Ezetimibe—atherosclerosis	0.000628	0.00438	CcSEcCtD
Mifepristone—Dry mouth—Lovastatin—atherosclerosis	0.000626	0.00437	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000623	0.00435	CcSEcCtD
Mifepristone—Muscle spasms—Niacin—atherosclerosis	0.000621	0.00433	CcSEcCtD
Mifepristone—Discomfort—Ezetimibe—atherosclerosis	0.00062	0.00433	CcSEcCtD
Mifepristone—Pain—Rosuvastatin—atherosclerosis	0.000619	0.00432	CcSEcCtD
Mifepristone—Constipation—Rosuvastatin—atherosclerosis	0.000619	0.00432	CcSEcCtD
Mifepristone—Dry mouth—Ezetimibe—atherosclerosis	0.000614	0.00428	CcSEcCtD
Mifepristone—Muscle spasms—Pravastatin—atherosclerosis	0.000611	0.00426	CcSEcCtD
Mifepristone—Infection—Lovastatin—atherosclerosis	0.00061	0.00425	CcSEcCtD
Mifepristone—Myalgia—Simvastatin—atherosclerosis	0.000599	0.00417	CcSEcCtD
Mifepristone—Arthralgia—Simvastatin—atherosclerosis	0.000599	0.00417	CcSEcCtD
Mifepristone—Infection—Ezetimibe—atherosclerosis	0.000598	0.00417	CcSEcCtD
Mifepristone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000597	0.00416	CcSEcCtD
Mifepristone—Anxiety—Simvastatin—atherosclerosis	0.000597	0.00416	CcSEcCtD
Mifepristone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000592	0.00413	CcSEcCtD
Mifepristone—Discomfort—Simvastatin—atherosclerosis	0.000592	0.00412	CcSEcCtD
Mifepristone—Nervous system disorder—Ezetimibe—atherosclerosis	0.00059	0.00412	CcSEcCtD
Mifepristone—Angioedema—Niacin—atherosclerosis	0.00059	0.00411	CcSEcCtD
Mifepristone—Ill-defined disorder—Pravastatin—atherosclerosis	0.00059	0.00411	CcSEcCtD
Mifepristone—Anorexia—Lovastatin—atherosclerosis	0.000585	0.00408	CcSEcCtD
Mifepristone—Skin disorder—Ezetimibe—atherosclerosis	0.000585	0.00408	CcSEcCtD
Mifepristone—Angioedema—Pravastatin—atherosclerosis	0.000581	0.00405	CcSEcCtD
Mifepristone—Urticaria—Rosuvastatin—atherosclerosis	0.000575	0.00401	CcSEcCtD
Mifepristone—Oedema—Simvastatin—atherosclerosis	0.000574	0.004	CcSEcCtD
Mifepristone—Malaise—Pravastatin—atherosclerosis	0.000573	0.004	CcSEcCtD
Mifepristone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000572	0.00399	CcSEcCtD
Mifepristone—Infection—Simvastatin—atherosclerosis	0.00057	0.00398	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000559	0.0039	CcSEcCtD
Mifepristone—Insomnia—Lovastatin—atherosclerosis	0.000555	0.00387	CcSEcCtD
Mifepristone—Myalgia—Niacin—atherosclerosis	0.00055	0.00383	CcSEcCtD
Mifepristone—Arthralgia—Niacin—atherosclerosis	0.00055	0.00383	CcSEcCtD
Mifepristone—Hypertension—Pravastatin—atherosclerosis	0.000549	0.00383	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000548	0.00382	CcSEcCtD
Mifepristone—Anorexia—Simvastatin—atherosclerosis	0.000547	0.00381	CcSEcCtD
Mifepristone—Dyspnoea—Lovastatin—atherosclerosis	0.000547	0.00381	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000546	0.00381	CcSEcCtD
Mifepristone—Insomnia—Ezetimibe—atherosclerosis	0.000544	0.0038	CcSEcCtD
Mifepristone—Myalgia—Pravastatin—atherosclerosis	0.000541	0.00377	CcSEcCtD
Mifepristone—Arthralgia—Pravastatin—atherosclerosis	0.000541	0.00377	CcSEcCtD
Mifepristone—Anxiety—Pravastatin—atherosclerosis	0.000539	0.00376	CcSEcCtD
Mifepristone—Dry mouth—Niacin—atherosclerosis	0.000538	0.00375	CcSEcCtD
Mifepristone—Dyspnoea—Ezetimibe—atherosclerosis	0.000537	0.00374	CcSEcCtD
Mifepristone—Discomfort—Pravastatin—atherosclerosis	0.000535	0.00373	CcSEcCtD
Mifepristone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000533	0.00372	CcSEcCtD
Mifepristone—Decreased appetite—Lovastatin—atherosclerosis	0.000533	0.00372	CcSEcCtD
Mifepristone—Fatigue—Lovastatin—atherosclerosis	0.000529	0.00369	CcSEcCtD
Mifepristone—Oedema—Niacin—atherosclerosis	0.000527	0.00367	CcSEcCtD
Mifepristone—Constipation—Lovastatin—atherosclerosis	0.000525	0.00366	CcSEcCtD
Mifepristone—Pain—Lovastatin—atherosclerosis	0.000525	0.00366	CcSEcCtD
Mifepristone—Decreased appetite—Ezetimibe—atherosclerosis	0.000523	0.00365	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000523	0.00365	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00052	0.00362	CcSEcCtD
Mifepristone—Asthenia—Rosuvastatin—atherosclerosis	0.000519	0.00362	CcSEcCtD
Mifepristone—Insomnia—Simvastatin—atherosclerosis	0.000519	0.00362	CcSEcCtD
Mifepristone—Oedema—Pravastatin—atherosclerosis	0.000519	0.00362	CcSEcCtD
Mifepristone—Fatigue—Ezetimibe—atherosclerosis	0.000519	0.00362	CcSEcCtD
Mifepristone—Infection—Pravastatin—atherosclerosis	0.000515	0.00359	CcSEcCtD
Mifepristone—Pain—Ezetimibe—atherosclerosis	0.000515	0.00359	CcSEcCtD
Mifepristone—Constipation—Ezetimibe—atherosclerosis	0.000515	0.00359	CcSEcCtD
Mifepristone—Pruritus—Rosuvastatin—atherosclerosis	0.000512	0.00357	CcSEcCtD
Mifepristone—Skin disorder—Niacin—atherosclerosis	0.000512	0.00357	CcSEcCtD
Mifepristone—Dyspnoea—Simvastatin—atherosclerosis	0.000512	0.00357	CcSEcCtD
Mifepristone—Feeling abnormal—Lovastatin—atherosclerosis	0.000506	0.00353	CcSEcCtD
Mifepristone—Anorexia—Niacin—atherosclerosis	0.000502	0.0035	CcSEcCtD
Mifepristone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000502	0.0035	CcSEcCtD
Mifepristone—Decreased appetite—Simvastatin—atherosclerosis	0.000499	0.00348	CcSEcCtD
Mifepristone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000496	0.00346	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000495	0.00346	CcSEcCtD
Mifepristone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000495	0.00345	CcSEcCtD
Mifepristone—Fatigue—Simvastatin—atherosclerosis	0.000495	0.00345	CcSEcCtD
Mifepristone—Anorexia—Pravastatin—atherosclerosis	0.000495	0.00345	CcSEcCtD
Mifepristone—Hypotension—Niacin—atherosclerosis	0.000492	0.00343	CcSEcCtD
Mifepristone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000492	0.00343	CcSEcCtD
Mifepristone—Constipation—Simvastatin—atherosclerosis	0.000491	0.00342	CcSEcCtD
Mifepristone—Pain—Simvastatin—atherosclerosis	0.000491	0.00342	CcSEcCtD
Mifepristone—Urticaria—Lovastatin—atherosclerosis	0.000487	0.0034	CcSEcCtD
Mifepristone—Abdominal pain—Lovastatin—atherosclerosis	0.000485	0.00338	CcSEcCtD
Mifepristone—Body temperature increased—Lovastatin—atherosclerosis	0.000485	0.00338	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00048	0.00335	CcSEcCtD
Mifepristone—Dizziness—Rosuvastatin—atherosclerosis	0.000479	0.00334	CcSEcCtD
Mifepristone—Urticaria—Ezetimibe—atherosclerosis	0.000478	0.00333	CcSEcCtD
Mifepristone—Insomnia—Niacin—atherosclerosis	0.000477	0.00332	CcSEcCtD
Mifepristone—Body temperature increased—Ezetimibe—atherosclerosis	0.000476	0.00332	CcSEcCtD
Mifepristone—Abdominal pain—Ezetimibe—atherosclerosis	0.000476	0.00332	CcSEcCtD
Mifepristone—Feeling abnormal—Simvastatin—atherosclerosis	0.000473	0.0033	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000473	0.0033	CcSEcCtD
Mifepristone—Dyspnoea—Niacin—atherosclerosis	0.00047	0.00328	CcSEcCtD
Mifepristone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000469	0.00327	CcSEcCtD
Mifepristone—Insomnia—Pravastatin—atherosclerosis	0.000469	0.00327	CcSEcCtD
Mifepristone—Somnolence—Niacin—atherosclerosis	0.000468	0.00327	CcSEcCtD
Mifepristone—Dyspnoea—Pravastatin—atherosclerosis	0.000463	0.00323	CcSEcCtD
Mifepristone—Decreased appetite—Niacin—atherosclerosis	0.000458	0.00319	CcSEcCtD
Mifepristone—Rash—Rosuvastatin—atherosclerosis	0.000456	0.00318	CcSEcCtD
Mifepristone—Dermatitis—Rosuvastatin—atherosclerosis	0.000456	0.00318	CcSEcCtD
Mifepristone—Urticaria—Simvastatin—atherosclerosis	0.000456	0.00318	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000455	0.00317	CcSEcCtD
Mifepristone—Abdominal pain—Simvastatin—atherosclerosis	0.000454	0.00316	CcSEcCtD
Mifepristone—Body temperature increased—Simvastatin—atherosclerosis	0.000454	0.00316	CcSEcCtD
Mifepristone—Headache—Rosuvastatin—atherosclerosis	0.000454	0.00316	CcSEcCtD
Mifepristone—PGR—connective tissue—atherosclerosis	0.000452	0.0479	CbGeAlD
Mifepristone—Hypersensitivity—Lovastatin—atherosclerosis	0.000452	0.00315	CcSEcCtD
Mifepristone—Decreased appetite—Pravastatin—atherosclerosis	0.000451	0.00315	CcSEcCtD
Mifepristone—Pain—Niacin—atherosclerosis	0.000451	0.00314	CcSEcCtD
Mifepristone—Fatigue—Pravastatin—atherosclerosis	0.000447	0.00312	CcSEcCtD
Mifepristone—Pain—Pravastatin—atherosclerosis	0.000444	0.00309	CcSEcCtD
Mifepristone—Constipation—Pravastatin—atherosclerosis	0.000444	0.00309	CcSEcCtD
Mifepristone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000443	0.00309	CcSEcCtD
Mifepristone—Asthenia—Lovastatin—atherosclerosis	0.00044	0.00307	CcSEcCtD
Mifepristone—Pruritus—Lovastatin—atherosclerosis	0.000434	0.00303	CcSEcCtD
Mifepristone—Asthenia—Ezetimibe—atherosclerosis	0.000432	0.00301	CcSEcCtD
Mifepristone—Gastrointestinal pain—Niacin—atherosclerosis	0.000431	0.003	CcSEcCtD
Mifepristone—Nausea—Rosuvastatin—atherosclerosis	0.00043	0.003	CcSEcCtD
Mifepristone—Feeling abnormal—Pravastatin—atherosclerosis	0.000428	0.00298	CcSEcCtD
Mifepristone—Pruritus—Ezetimibe—atherosclerosis	0.000426	0.00297	CcSEcCtD
Mifepristone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000424	0.00296	CcSEcCtD
Mifepristone—Hypersensitivity—Simvastatin—atherosclerosis	0.000423	0.00295	CcSEcCtD
Mifepristone—Diarrhoea—Lovastatin—atherosclerosis	0.00042	0.00293	CcSEcCtD
Mifepristone—Urticaria—Niacin—atherosclerosis	0.000419	0.00292	CcSEcCtD
Mifepristone—Abdominal pain—Niacin—atherosclerosis	0.000417	0.0029	CcSEcCtD
Mifepristone—Body temperature increased—Niacin—atherosclerosis	0.000417	0.0029	CcSEcCtD
Mifepristone—Urticaria—Pravastatin—atherosclerosis	0.000412	0.00287	CcSEcCtD
Mifepristone—Asthenia—Simvastatin—atherosclerosis	0.000412	0.00287	CcSEcCtD
Mifepristone—Diarrhoea—Ezetimibe—atherosclerosis	0.000412	0.00287	CcSEcCtD
Mifepristone—Body temperature increased—Pravastatin—atherosclerosis	0.00041	0.00286	CcSEcCtD
Mifepristone—Abdominal pain—Pravastatin—atherosclerosis	0.00041	0.00286	CcSEcCtD
Mifepristone—Pruritus—Simvastatin—atherosclerosis	0.000406	0.00283	CcSEcCtD
Mifepristone—Dizziness—Lovastatin—atherosclerosis	0.000406	0.00283	CcSEcCtD
Mifepristone—CYP3A7—liver—atherosclerosis	0.000402	0.0425	CbGeAlD
Mifepristone—Dizziness—Ezetimibe—atherosclerosis	0.000398	0.00278	CcSEcCtD
Mifepristone—PGR—cardiovascular system—atherosclerosis	0.000394	0.0416	CbGeAlD
Mifepristone—Diarrhoea—Simvastatin—atherosclerosis	0.000393	0.00274	CcSEcCtD
Mifepristone—Vomiting—Lovastatin—atherosclerosis	0.00039	0.00272	CcSEcCtD
Mifepristone—Hypersensitivity—Niacin—atherosclerosis	0.000388	0.00271	CcSEcCtD
Mifepristone—Rash—Lovastatin—atherosclerosis	0.000387	0.0027	CcSEcCtD
Mifepristone—Dermatitis—Lovastatin—atherosclerosis	0.000387	0.0027	CcSEcCtD
Mifepristone—Headache—Lovastatin—atherosclerosis	0.000384	0.00268	CcSEcCtD
Mifepristone—Vomiting—Ezetimibe—atherosclerosis	0.000383	0.00267	CcSEcCtD
Mifepristone—Hypersensitivity—Pravastatin—atherosclerosis	0.000382	0.00267	CcSEcCtD
Mifepristone—Dizziness—Simvastatin—atherosclerosis	0.00038	0.00265	CcSEcCtD
Mifepristone—Rash—Ezetimibe—atherosclerosis	0.000379	0.00265	CcSEcCtD
Mifepristone—Dermatitis—Ezetimibe—atherosclerosis	0.000379	0.00264	CcSEcCtD
Mifepristone—Asthenia—Niacin—atherosclerosis	0.000378	0.00264	CcSEcCtD
Mifepristone—Headache—Ezetimibe—atherosclerosis	0.000377	0.00263	CcSEcCtD
Mifepristone—Pruritus—Niacin—atherosclerosis	0.000373	0.0026	CcSEcCtD
Mifepristone—Asthenia—Pravastatin—atherosclerosis	0.000372	0.0026	CcSEcCtD
Mifepristone—Pruritus—Pravastatin—atherosclerosis	0.000367	0.00256	CcSEcCtD
Mifepristone—Vomiting—Simvastatin—atherosclerosis	0.000365	0.00254	CcSEcCtD
Mifepristone—Nausea—Lovastatin—atherosclerosis	0.000364	0.00254	CcSEcCtD
Mifepristone—Rash—Simvastatin—atherosclerosis	0.000362	0.00252	CcSEcCtD
Mifepristone—Dermatitis—Simvastatin—atherosclerosis	0.000362	0.00252	CcSEcCtD
Mifepristone—Diarrhoea—Niacin—atherosclerosis	0.000361	0.00251	CcSEcCtD
Mifepristone—AR—connective tissue—atherosclerosis	0.00036	0.0381	CbGeAlD
Mifepristone—Headache—Simvastatin—atherosclerosis	0.00036	0.00251	CcSEcCtD
Mifepristone—Nausea—Ezetimibe—atherosclerosis	0.000357	0.00249	CcSEcCtD
Mifepristone—Diarrhoea—Pravastatin—atherosclerosis	0.000355	0.00248	CcSEcCtD
Mifepristone—Dizziness—Niacin—atherosclerosis	0.000348	0.00243	CcSEcCtD
Mifepristone—PGR—adipose tissue—atherosclerosis	0.000347	0.0367	CbGeAlD
Mifepristone—Dizziness—Pravastatin—atherosclerosis	0.000343	0.00239	CcSEcCtD
Mifepristone—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000342	0.0362	CbGeAlD
Mifepristone—Nausea—Simvastatin—atherosclerosis	0.000341	0.00238	CcSEcCtD
Mifepristone—Vomiting—Niacin—atherosclerosis	0.000335	0.00234	CcSEcCtD
Mifepristone—Rash—Niacin—atherosclerosis	0.000332	0.00232	CcSEcCtD
Mifepristone—Dermatitis—Niacin—atherosclerosis	0.000332	0.00231	CcSEcCtD
Mifepristone—Headache—Niacin—atherosclerosis	0.00033	0.0023	CcSEcCtD
Mifepristone—Vomiting—Pravastatin—atherosclerosis	0.00033	0.0023	CcSEcCtD
Mifepristone—Rash—Pravastatin—atherosclerosis	0.000327	0.00228	CcSEcCtD
Mifepristone—Dermatitis—Pravastatin—atherosclerosis	0.000327	0.00228	CcSEcCtD
Mifepristone—Headache—Pravastatin—atherosclerosis	0.000325	0.00227	CcSEcCtD
Mifepristone—AR—cardiovascular system—atherosclerosis	0.000314	0.0332	CbGeAlD
Mifepristone—Nausea—Niacin—atherosclerosis	0.000313	0.00218	CcSEcCtD
Mifepristone—Nausea—Pravastatin—atherosclerosis	0.000308	0.00215	CcSEcCtD
Mifepristone—AR—adipose tissue—atherosclerosis	0.000277	0.0293	CbGeAlD
Mifepristone—ABCB1—blood vessel—atherosclerosis	0.000273	0.0288	CbGeAlD
Mifepristone—ABCC1—adipose tissue—atherosclerosis	0.000263	0.0278	CbGeAlD
Mifepristone—NR3C1—connective tissue—atherosclerosis	0.000261	0.0276	CbGeAlD
Mifepristone—NR3C1—cardiovascular system—atherosclerosis	0.000227	0.024	CbGeAlD
Mifepristone—CYP3A5—adipose tissue—atherosclerosis	0.000202	0.0214	CbGeAlD
Mifepristone—NR3C1—adipose tissue—atherosclerosis	0.0002	0.0212	CbGeAlD
Mifepristone—AR—liver—atherosclerosis	0.000194	0.0205	CbGeAlD
Mifepristone—ABCC1—liver—atherosclerosis	0.000184	0.0195	CbGeAlD
Mifepristone—CYP3A5—liver—atherosclerosis	0.000142	0.015	CbGeAlD
Mifepristone—NR3C1—liver—atherosclerosis	0.00014	0.0149	CbGeAlD
Mifepristone—ABCB1—cardiovascular system—atherosclerosis	0.000122	0.0129	CbGeAlD
Mifepristone—ABCB1—adipose tissue—atherosclerosis	0.000107	0.0113	CbGeAlD
Mifepristone—CYP3A4—liver—atherosclerosis	0.000106	0.0112	CbGeAlD
Mifepristone—CYP2D6—liver—atherosclerosis	0.000105	0.0111	CbGeAlD
Mifepristone—ABCB1—liver—atherosclerosis	7.52e-05	0.00795	CbGeAlD
Mifepristone—CYP2D6—Metabolism—FABP4—atherosclerosis	1.87e-05	0.000212	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOA4—atherosclerosis	1.84e-05	0.000208	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PDGFB—atherosclerosis	1.83e-05	0.000207	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCA1—atherosclerosis	1.82e-05	0.000205	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.81e-05	0.000205	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.81e-05	0.000204	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPARG—atherosclerosis	1.79e-05	0.000202	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AGT—atherosclerosis	1.79e-05	0.000202	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.79e-05	0.000202	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—HMOX1—atherosclerosis	1.79e-05	0.000202	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.77e-05	0.0002	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTHFR—atherosclerosis	1.76e-05	0.000198	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APOE—atherosclerosis	1.75e-05	0.000198	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—LEP—atherosclerosis	1.75e-05	0.000198	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CAV1—atherosclerosis	1.74e-05	0.000196	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.74e-05	0.000196	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.73e-05	0.000196	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APOA1—atherosclerosis	1.73e-05	0.000196	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOB—atherosclerosis	1.71e-05	0.000193	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PDGFB—atherosclerosis	1.71e-05	0.000193	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.7e-05	0.000192	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—LIPC—atherosclerosis	1.69e-05	0.000191	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALOX15—atherosclerosis	1.68e-05	0.00019	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOA2—atherosclerosis	1.68e-05	0.00019	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.68e-05	0.00019	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.68e-05	0.00019	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOC3—atherosclerosis	1.68e-05	0.000189	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ESR1—atherosclerosis	1.67e-05	0.000189	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.67e-05	0.000189	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—LDLR—atherosclerosis	1.67e-05	0.000188	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTM1—atherosclerosis	1.66e-05	0.000188	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ABCG5—atherosclerosis	1.66e-05	0.000187	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—F2—atherosclerosis	1.65e-05	0.000187	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.65e-05	0.000186	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.65e-05	0.000186	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARA—atherosclerosis	1.64e-05	0.000186	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APOE—atherosclerosis	1.63e-05	0.000185	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—LPL—atherosclerosis	1.63e-05	0.000185	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CETP—atherosclerosis	1.63e-05	0.000184	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.62e-05	0.000183	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CAV1—atherosclerosis	1.62e-05	0.000183	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APOA1—atherosclerosis	1.62e-05	0.000183	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SERPINE1—atherosclerosis	1.61e-05	0.000182	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—LPA—atherosclerosis	1.6e-05	0.000181	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GPX1—atherosclerosis	1.59e-05	0.00018	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOA2—atherosclerosis	1.58e-05	0.000179	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.58e-05	0.000179	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.58e-05	0.000179	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.58e-05	0.000179	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CG—atherosclerosis	1.58e-05	0.000179	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.56e-05	0.000177	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.56e-05	0.000176	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.56e-05	0.000176	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—BGN—atherosclerosis	1.55e-05	0.000175	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CD36—atherosclerosis	1.55e-05	0.000175	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOA5—atherosclerosis	1.54e-05	0.000174	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS2—atherosclerosis	1.52e-05	0.000172	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—LPA—atherosclerosis	1.51e-05	0.000171	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—INS—atherosclerosis	1.5e-05	0.000169	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOB—atherosclerosis	1.49e-05	0.000169	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR1—atherosclerosis	1.49e-05	0.000168	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.48e-05	0.000167	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCL2—atherosclerosis	1.47e-05	0.000167	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.47e-05	0.000166	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MTHFR—atherosclerosis	1.47e-05	0.000166	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.47e-05	0.000166	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—BGN—atherosclerosis	1.46e-05	0.000165	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.45e-05	0.000164	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF1—atherosclerosis	1.45e-05	0.000164	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOA5—atherosclerosis	1.45e-05	0.000164	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARA—atherosclerosis	1.44e-05	0.000163	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALOX5—atherosclerosis	1.43e-05	0.000161	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—LPL—atherosclerosis	1.42e-05	0.000161	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AGT—atherosclerosis	1.4e-05	0.000158	CbGpPWpGaD
Mifepristone—ABCC1—Disease—INS—atherosclerosis	1.4e-05	0.000158	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.39e-05	0.000157	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GPX1—atherosclerosis	1.39e-05	0.000157	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAPK3—atherosclerosis	1.38e-05	0.000156	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SERPINE1—atherosclerosis	1.38e-05	0.000155	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.37e-05	0.000155	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOE—atherosclerosis	1.37e-05	0.000155	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—atherosclerosis	1.36e-05	0.000153	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CAV1—atherosclerosis	1.36e-05	0.000153	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CD36—atherosclerosis	1.35e-05	0.000153	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOA1—atherosclerosis	1.35e-05	0.000153	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.35e-05	0.000152	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOS3—atherosclerosis	1.31e-05	0.000148	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.31e-05	0.000148	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.3e-05	0.000147	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SERPINE1—atherosclerosis	1.28e-05	0.000145	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.28e-05	0.000145	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NAMPT—atherosclerosis	1.28e-05	0.000145	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—LIPC—atherosclerosis	1.27e-05	0.000144	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOC3—atherosclerosis	1.27e-05	0.000143	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARA—atherosclerosis	1.26e-05	0.000142	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—LDLR—atherosclerosis	1.26e-05	0.000142	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CG—atherosclerosis	1.24e-05	0.00014	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CETP—atherosclerosis	1.23e-05	0.000139	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—FABP4—atherosclerosis	1.23e-05	0.000138	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LCAT—atherosclerosis	1.23e-05	0.000138	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS3—atherosclerosis	1.22e-05	0.000138	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	1.22e-05	0.000138	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AGT—atherosclerosis	1.22e-05	0.000138	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.21e-05	0.000136	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.21e-05	0.000136	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOA4—atherosclerosis	1.2e-05	0.000136	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—LIPC—atherosclerosis	1.2e-05	0.000136	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOE—atherosclerosis	1.19e-05	0.000135	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—atherosclerosis	1.19e-05	0.000135	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOC3—atherosclerosis	1.19e-05	0.000135	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—LDLR—atherosclerosis	1.19e-05	0.000134	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CAV1—atherosclerosis	1.18e-05	0.000134	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.18e-05	0.000133	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOA1—atherosclerosis	1.18e-05	0.000133	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SCARB1—atherosclerosis	1.18e-05	0.000133	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—INS—atherosclerosis	1.17e-05	0.000132	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—atherosclerosis	1.17e-05	0.000132	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CETP—atherosclerosis	1.16e-05	0.000131	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.13e-05	0.000127	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—atherosclerosis	1.12e-05	0.000127	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HMGCR—atherosclerosis	1.11e-05	0.000126	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.11e-05	0.000125	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.09e-05	0.000123	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.09e-05	0.000123	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOB—atherosclerosis	1.08e-05	0.000122	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CG—atherosclerosis	1.08e-05	0.000122	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALB—atherosclerosis	1.07e-05	0.000121	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—atherosclerosis	1.05e-05	0.000119	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAPK3—atherosclerosis	1.05e-05	0.000119	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.05e-05	0.000119	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.05e-05	0.000118	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NFKB1—atherosclerosis	1.04e-05	0.000118	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—atherosclerosis	1.04e-05	0.000118	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.04e-05	0.000117	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.04e-05	0.000117	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.04e-05	0.000117	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOA2—atherosclerosis	1.04e-05	0.000117	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—LPL—atherosclerosis	1.03e-05	0.000116	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NOS3—atherosclerosis	1.03e-05	0.000116	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK8—atherosclerosis	1.03e-05	0.000116	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.02e-05	0.000116	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—INS—atherosclerosis	1.02e-05	0.000115	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GPX1—atherosclerosis	1e-05	0.000114	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ABCA1—atherosclerosis	9.9e-06	0.000112	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LPA—atherosclerosis	9.87e-06	0.000112	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CD36—atherosclerosis	9.78e-06	0.000111	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—BGN—atherosclerosis	9.56e-06	0.000108	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOA5—atherosclerosis	9.47e-06	0.000107	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—atherosclerosis	9.47e-06	0.000107	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—atherosclerosis	9.38e-06	0.000106	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—atherosclerosis	9.37e-06	0.000106	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALB—atherosclerosis	9.35e-06	0.000106	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCA1—atherosclerosis	9.33e-06	0.000105	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—atherosclerosis	9.29e-06	0.000105	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MTHFR—atherosclerosis	9.27e-06	0.000105	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.11e-06	0.000103	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARA—atherosclerosis	9.1e-06	0.000103	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK3—atherosclerosis	8.95e-06	0.000101	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NOS3—atherosclerosis	8.95e-06	0.000101	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AGT—atherosclerosis	8.81e-06	9.95e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.8e-06	9.94e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—atherosclerosis	8.74e-06	9.87e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—atherosclerosis	8.69e-06	9.82e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOE—atherosclerosis	8.63e-06	9.75e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CAV1—atherosclerosis	8.55e-06	9.66e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOA1—atherosclerosis	8.53e-06	9.64e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HMOX1—atherosclerosis	8.5e-06	9.6e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK3—atherosclerosis	8.35e-06	9.43e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—atherosclerosis	8.18e-06	9.24e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOB—atherosclerosis	8.14e-06	9.19e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—atherosclerosis	8.1e-06	9.15e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.01e-06	9.04e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAPK3—atherosclerosis	7.96e-06	8.99e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—atherosclerosis	7.92e-06	8.94e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.89e-06	8.92e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LIPC—atherosclerosis	7.84e-06	8.86e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOC3—atherosclerosis	7.8e-06	8.81e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CG—atherosclerosis	7.79e-06	8.8e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—LPL—atherosclerosis	7.77e-06	8.78e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LDLR—atherosclerosis	7.75e-06	8.75e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOB—atherosclerosis	7.67e-06	8.66e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPX1—atherosclerosis	7.58e-06	8.56e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CETP—atherosclerosis	7.57e-06	8.55e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—atherosclerosis	7.52e-06	8.49e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.46e-06	8.43e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CD36—atherosclerosis	7.38e-06	8.34e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—INS—atherosclerosis	7.37e-06	8.33e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—LPL—atherosclerosis	7.32e-06	8.27e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.25e-06	8.19e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPX1—atherosclerosis	7.14e-06	8.07e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—atherosclerosis	7.08e-06	8e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTHFR—atherosclerosis	7e-06	7.9e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CD36—atherosclerosis	6.96e-06	7.86e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARA—atherosclerosis	6.86e-06	7.75e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.84e-06	7.73e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALB—atherosclerosis	6.76e-06	7.64e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AGT—atherosclerosis	6.65e-06	7.51e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.59e-06	7.45e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—atherosclerosis	6.55e-06	7.4e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOE—atherosclerosis	6.51e-06	7.36e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARA—atherosclerosis	6.47e-06	7.31e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NOS3—atherosclerosis	6.47e-06	7.31e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CAV1—atherosclerosis	6.45e-06	7.29e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOA1—atherosclerosis	6.44e-06	7.27e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AGT—atherosclerosis	6.26e-06	7.08e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOE—atherosclerosis	6.14e-06	6.93e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—atherosclerosis	6.1e-06	6.89e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.1e-06	6.89e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CAV1—atherosclerosis	6.08e-06	6.87e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOA1—atherosclerosis	6.07e-06	6.85e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—atherosclerosis	6.04e-06	6.82e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.91e-06	6.68e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.88e-06	6.64e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—atherosclerosis	5.67e-06	6.41e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—atherosclerosis	5.63e-06	6.36e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—INS—atherosclerosis	5.56e-06	6.29e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.54e-06	6.26e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—atherosclerosis	5.37e-06	6.07e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—atherosclerosis	5.35e-06	6.04e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—INS—atherosclerosis	5.24e-06	5.92e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.23e-06	5.91e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALB—atherosclerosis	5.1e-06	5.76e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOB—atherosclerosis	5.01e-06	5.66e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NOS3—atherosclerosis	4.88e-06	5.51e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.88e-06	5.51e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALB—atherosclerosis	4.81e-06	5.43e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LPL—atherosclerosis	4.79e-06	5.41e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—atherosclerosis	4.71e-06	5.33e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPX1—atherosclerosis	4.67e-06	5.28e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NOS3—atherosclerosis	4.6e-06	5.19e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CD36—atherosclerosis	4.55e-06	5.14e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—atherosclerosis	4.46e-06	5.04e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.31e-06	4.87e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARA—atherosclerosis	4.23e-06	4.78e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.21e-06	4.75e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—atherosclerosis	4.11e-06	4.65e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AGT—atherosclerosis	4.1e-06	4.63e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOE—atherosclerosis	4.01e-06	4.53e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CAV1—atherosclerosis	3.98e-06	4.49e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOA1—atherosclerosis	3.97e-06	4.48e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.62e-06	4.09e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—atherosclerosis	3.5e-06	3.95e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—INS—atherosclerosis	3.43e-06	3.87e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALB—atherosclerosis	3.14e-06	3.55e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NOS3—atherosclerosis	3.01e-06	3.4e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—atherosclerosis	2.97e-06	3.36e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.75e-06	3.11e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—atherosclerosis	2.24e-06	2.53e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—atherosclerosis	2.11e-06	2.39e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—atherosclerosis	1.38e-06	1.56e-05	CbGpPWpGaD
